4 diabetes tech execs on the future of multi-analyte glucose sensors

Executives with Abbott, PercuSense and Biolinq spoke with MedTech Dive about what’s next with multi-analyte sensor technology.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top